Lasa Supergenerics Share PriceLasa Supergenerics

₹26.9
-0.1 (-0.37%)
As on 22 September, 2023 | 23:00 BSE: 540702 NSE: LASAISIN: INE670X01014

Lasa Supergenerics Performance

Day Range

  • Low 26.3
  • High 27.3
26.9

52 Week Range

  • Low 17.1
  • High 43
26.9
  • Open Price26.6
  • Previous Close27
  • Volume33546

Start SIP in Lasa Supergenerics

Start SIP

Lasa Supergenerics Share Price

  • Over 1 Month 10.7%
  • Over 3 Month 24.25%
  • Over 6 Month 24.25%
  • Over 1 Year -35.34%

Lasa Supergenerics Key Statistics

P/E Ratio -4.3
PEG Ratio 0.1
Market Cap Cr 135
Price to Book Ratio 1.1
EPS -3.9
Dividend 0
Relative Strength Index 45.68
Money Flow Index 13.46
MACD Signal 0.83
Average True Range 1.66

Lasa Supergenerics Investment Rating

  • Master Rating:
  • Lasa Supergenerics has an operating revenue of Rs. 131.25 Cr. on a trailing 12-month basis. An annual revenue de-growth of -4% needs improvement, Pre-tax margin of -33% needs improvement, ROE of -32% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 5% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 24 which is a POOR score indicating inconsistency in earnings, a RS Rating of 34 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 45 indicates it belongs to a fair industry group of Medical-Ethical Drugs and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Lasa Supergenerics Financials
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 313532342951
Operating Expenses Qtr Cr 273134343740
Operating Profit Qtr Cr 44-20-811
Depreciation Qtr Cr 343333
Interest Qtr Cr 000100
Tax Qtr Cr 6-4001-1
Net Profit Qtr Cr -5-15-5-7-1212
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 131137
Operating Expenses Annual Cr 136121
Operating Profit Annual in Cr -716
Depreciation Cr 1314
Interest Annual Cr 40
Tax Annual Cr -4-1
Net Profit Annual Cr -39-5
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 10
Cash from Investing Activity Annual Cr -3
Cash from Financing Annual Activity Cr 0
Net Cash Flow Annual Cr 7
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 118149
Fixed Assets Annual Cr 124127
Total Non Current Assets Annual Cr 125127
Total Current Assets Annual Cr 3972
Total Assets Annual Cr 164199
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 2437
ROE Annual % -33-4
ROCE Annual % -151
Total Debt to Total Equity Annual --
EBDIT Annual Margin % -411
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual --
EBDIT Annual Margin %

Lasa Supergenerics Technicals

EMA & SMA

Current Price
₹26.9
-0.1 (-0.37%)
  • Bullish Moving Average
  • ___
  • 6
  • Bearish Moving Average
  • ___
  • 10
  • 20 Day
  • ₹27.95
  • 50 Day
  • ₹26.57
  • 100 Day
  • ₹25.71
  • 200 Day
  • ₹27.46
  • 20 Day
  • ₹29
  • 50 Day
  • ₹25.85
  • 100 Day
  • ₹24.52
  • 200 Day
  • ₹25.64

Lasa Supergenerics Resistance and Support

PIVOT
₹26.84
Resistance
First Resistance ₹27.37
Second Resistance ₹27.84
Third Resistance ₹28.37
RSI 45.68
MFI 13.46
MACD Single Line 0.83
MACD 0.31
Support
First Resistance ₹26.37
Second Resistance ₹25.84
Third Resistance ₹25.37

Lasa Supergenerics Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 41,760 4,176,000 100
Week 54,036 5,403,625 100
1 Month 289,581 15,828,518 54.66
6 Month 150,351 8,780,507 58.4

Lasa Supergenerics Result Highlights

Lasa Supergenerics Synopsis

NSE-Medical-Ethical Drugs

Lasa Supergenerics is involved in the business activities of Manufacture of veterinary preparations. Company’s Total Operating Revenue is Rs. 129.57 Cr. and Equity Capital is Rs. 50.10 Cr. for the Year ended 31/03/2023. Lasa Supergenerics Ltd. is a Public Limited Listed company incorporated on 11/11/2016 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24233MH2016PLC274202 and registration number is 274202.
Market Cap 134
Sales 131
Shares in Float 2.30
No of funds 1
Yield 1.14
Book Value 1.14
U/D Vol ratio 2.6
LTDebt / Equity
Alpha -0.09
Beta 0.94

Lasa Supergenerics

Owner NameJun-23Mar-23Jan-23Dec-22
Promoters 53.65%53.65%53.65%43.78%
Mutual Funds
Insurance Companies
Foreign Portfolio Investors
Financial Institutions/ Banks
Individual Investors 33.87%33.87%31.29%38.13%
Others 12.48%12.48%15.06%18.09%

Lasa Supergenerics Management

Name Designation
Dr. Omkar Pravin Herlekar Chairman & Managing Director
Mr. Shivanand G Hegde Whole Time Director
Mr. Hardesh Raja Tolani Independent Director
Ms. Ekta Avtar Gurnasinghani Independent Director
Mr. Ajay Hareshlal Sukhwani Independent Director
Ms. Manali Roop Bhagtani Independent Director

Lasa Supergenerics Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Lasa Supergenerics Corporate Action

Date Purpose Remarks
2023-08-14 Quarterly Results
2023-06-07 Audited Results (Revised) per share(2.5%)Final Dividend
2023-02-14 Quarterly Results
2022-11-14 Quarterly Results
2022-08-08 Quarterly Results

Lasa Supergenerics MF Shareholding

Name Amount(cr)
Motilal Oswal S&P BSE Healthcare ETF 8
  • Company Name
  • CMP
  • Chg(%)
  • Company Name
  • CMP
  • Chg(%)

Lasa Supergenerics FAQs

What is Share Price of Lasa Supergenerics ?

Lasa Supergenerics share price is ₹26 As on 22 September, 2023 | 22:46

What is the Market Cap of Lasa Supergenerics ?

The Market Cap of Lasa Supergenerics is ₹134.8 Cr As on 22 September, 2023 | 22:46

What is the P/E ratio of Lasa Supergenerics ?

The P/E ratio of Lasa Supergenerics is -4.3 As on 22 September, 2023 | 22:46

What is the PB ratio of Lasa Supergenerics ?

The PB ratio of Lasa Supergenerics is 1.1 As on 22 September, 2023 | 22:46

Q2FY23